homocysteine has been researched along with cyclic gmp in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Doherty, NS; Gieske, TH; Raddatz, R; Stephens, D | 1 |
| Jaraki, O; Loscalzo, J; Mullins, M; Osborne, JA; Rabbani, LE; Singel, D; Stamler, JS | 1 |
| Akita, T; Duan, J; Ikeda, H; Imaizumi, T; Murohara, T; Sasaki, K; Shimada, T; Shintani, S | 1 |
| Angelini, GD; Jeremy, JY; Mikhailidis, DP; Shukla, N; Thompson, CS | 1 |
| Cuniberti, LA; Dominguez, GN; Fischer, PA; Martinez, V; Masnatta, LD; Ramirez, AJ; Werba, JP | 1 |
| Akita, T; Duan, J; Egami, K; Ikeda, H; Imaizumi, T; Murohara, T; Sasaki, K; Shimada, T; Shintani, S | 1 |
| Bailey, SR; Berhane, Y; Elliott, J; Griffiths, MJ; Harris, PA | 1 |
| Falcinelli, F; Floridi, A; Gresele, P; Imperiali, P; Migliacci, R; Nenci, GG | 1 |
| Seftel, AD | 1 |
| Angelini, GD; Jeremy, JY; Jones, RA; Koupparis, A; Persad, R; Shukla, N | 1 |
| Armani, U; Cerone, R; Leoncini, G; Minniti, G; Piana, A; Signorello, MG; Viviani, GL | 1 |
| Bian, K; Hu, SJ; Qiu, LH; Sun, J; Xia, Q; Xie, XJ; Zhang, BQ; Zhu, JH; Zhu, ZH | 1 |
| Leoncini, G; Passalacqua, M; Segantin, A; Signorello, MG | 1 |
| Bernecker, C; Fazekas, F; Gruber, HJ; Horejsi, R; Lechner, A; Möller, R; Pailer, S; Truschnig-Wilders, M | 1 |
| Chang, NB; He, YZ; Jiang, J; Jiang, R; Li, T; Sun, XL; Xu, JY | 1 |
| Cheong, YK; Choi, SW; Chung, HT; Jeong, SO; Kim, SH; Lee, JH; Pae, HO; Son, Y | 1 |
| Lai, B; Luo, Z; Wang, N; Wang, X; Xiao, L; Xie, X; Zhang, Z | 1 |
| He, G; Hou, H; Sun, W; Xue, H; Yang, Q; Zhou, Y | 1 |
18 other study(ies) available for homocysteine and cyclic gmp
| Article | Year |
|---|---|
S-adenosylhomocysteine levels are not involved in the spasmolytic activity of 3-deazaadenosine in guinea-pig lung parenchyma.
Topics: Adenosine; Animals; Cyclic AMP; Cyclic GMP; Guinea Pigs; Homocysteine; In Vitro Techniques; Lung; Male; Parasympatholytics; S-Adenosylhomocysteine; SRS-A; Tubercidin | 1991 |
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
Topics: Adenosine Diphosphate; Animals; Aorta; Blood Platelets; Cattle; Cells, Cultured; Collagen; Copper; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Homocysteine; Homocystine; Humans; Hydrogen Peroxide; In Vitro Techniques; Iron; Kinetics; Luminescent Measurements; Magnetic Resonance Spectroscopy; Models, Cardiovascular; Nitric Oxide; Nitrogen Oxides; Platelet Aggregation; Platelet Aggregation Inhibitors | 1993 |
Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia.
Topics: Angiography; Animals; Arginine; Blood Pressure; Body Weight; Collateral Circulation; Cyclic GMP; Disease Models, Animal; Heart Rate; Hindlimb; Homocysteine; Hyperhomocysteinemia; Immunohistochemistry; Ischemia; Laser-Doppler Flowmetry; Muscle, Skeletal; Neovascularization, Physiologic; Nitrates; Nitrites; Rats; Regional Blood Flow; Time Factors | 2000 |
Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits.
Topics: Acetylcholine; Animals; Aorta; Cyclic GMP; Diabetes Mellitus, Experimental; Endothelium, Vascular; Homocysteine; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitroprusside; Phenylephrine; Rabbits; Reference Values; Vasodilation | 2002 |
Hyperhomocysteinemia induces renal hemodynamic dysfunction: is nitric oxide involved?
Topics: Animals; Cyclic GMP; Homocysteine; Hyperhomocysteinemia; Kidney Diseases; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Renal Circulation; Thiobarbituric Acid Reactive Substances; Tyrosine | 2003 |
Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation.
Topics: Administration, Oral; Animals; Cholesterol; Cholesterol, HDL; Cyclic GMP; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Folic Acid; Hindlimb; Homocysteine; Hypercholesterolemia; Ischemia; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peripheral Vascular Diseases; Rats; Rats, Sprague-Dawley; Risk Factors; Severity of Illness Index | 2003 |
In vitro and in vivo studies of homocysteine in equine tissues: implications for the pathophysiology of laminitis.
Topics: Animals; Case-Control Studies; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclic GMP; Endothelial Cells; Endothelium, Vascular; Foot Diseases; Homocysteine; Hoof and Claw; Horse Diseases; Horses; Inflammation; Nitric Oxide; Risk Factors; Seasons; Vasodilation | 2004 |
Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Cyclic GMP; Diastole; Endothelium, Vascular; Female; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Nitrates; Nitrites; Regional Blood Flow; Renal Circulation; Renal Dialysis; Risk Factors; Statistics as Topic; Systole; Time Factors; Treatment Outcome; Vascular Diseases; Vasodilation | 2004 |
Cavernosal dysfunction in a rabbit model of hyperhomocysteinaemia.
Topics: Animals; Cyclic GMP; Disease Models, Animal; Homocysteine; Hyperhomocysteinemia; Impotence, Vasculogenic; Male; Muscle, Smooth, Vascular; Nitric Oxide; Organ Culture Techniques; Penis; Rabbits; Risk Factors; Superoxides; Veins | 2005 |
Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit.
Topics: Acetophenones; Acetylcholine; Administration, Oral; Animals; Aorta; Blotting, Western; Cyclic GMP; Dietary Supplements; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Homocysteine; Hyperhomocysteinemia; In Vitro Techniques; Methionine; NADPH Oxidases; Nitric Oxide Donors; Nitroprusside; Onium Compounds; Penicillamine; Rabbits; Superoxides; Time Factors; Vasodilation; Vasodilator Agents | 2006 |
Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus.
Topics: Aged; Case-Control Studies; Cyclic GMP; Diabetes Mellitus, Type 2; Glutathione; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Platelet Activation; Reactive Oxygen Species | 2007 |
Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine.
Topics: Acetylcholine; Animals; Antioxidants; Aorta, Thoracic; Astragalus propinquus; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Endothelial Cells; gamma-Aminobutyric Acid; Homocysteine; Humans; In Vitro Techniques; Male; Nitric Oxide; Plant Extracts; Plant Roots; Polysaccharides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Saponins; Superoxide Dismutase; Vasodilation; Vasodilator Agents | 2007 |
Homocysteine decreases platelet NO level via protein kinase C activation.
Topics: Analysis of Variance; Blood Platelets; Citrulline; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Homocysteine; Humans; Microscopy, Fluorescence; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Protein Kinase C; Superoxides; Tyrosine | 2009 |
Increased dopamine is associated with the cGMP and homocysteine pathway in female migraineurs.
Topics: Adult; Biomarkers; Brain; Cyclic GMP; Dopamine; Female; Homocysteine; Humans; Inflammation Mediators; Interleukins; Iron; Male; Middle Aged; Migraine Disorders; Predictive Value of Tests; Sex Characteristics; Up-Regulation | 2010 |
Endothelial Cells Inhibit the Angiotensin II Induced Phenotypic Modulation of Rat Vascular Adventitial Fibroblasts.
Topics: Actins; Adventitia; Angiotensin II; Animals; Aorta, Thoracic; Arginine; Cells, Cultured; Coculture Techniques; Collagen Type I; Cyclic GMP; Endothelial Cells; Fibroblasts; Homocysteine; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Signal Transduction | 2017 |
Both nitric oxide and nitrite prevent homocysteine-induced endoplasmic reticulum stress and subsequent apoptosis via cGMP-dependent pathway in neuronal cells.
Topics: Animals; Apoptosis; Cell Line; Cyclic GMP; Endoplasmic Reticulum Stress; Homocysteine; Mice; Neurons; Neuroprotective Agents; Nitric Oxide; Nitrites; Signal Transduction | 2017 |
Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine.
Topics: Animals; Aorta, Thoracic; Biopterins; Cattle; Cell Line; Cyclic GMP; Endothelial Cells; Endothelium, Vascular; Homocysteine; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase Type III; Proline; Rats, Sprague-Dawley; Renal Artery; Vasodilation | 2018 |
Endoplasmic reticulum stress mediates homocysteine-induced hypertrophy of cardiac cells through activation of cyclic nucleotide phosphodiesterase 1C.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Endoplasmic Reticulum Stress; Enzyme Activation; Homocysteine; Myocytes, Cardiac; Phosphoric Diester Hydrolases; Rats; Taurochenodeoxycholic Acid | 2022 |